Sleep apnea pill study tests two doses against placebo
NCT ID NCT04726982
Summary
This study aimed to find the most effective dose of the drug acetazolamide for treating obstructive sleep apnea (OSA). It compared a low dose, a high dose, and a placebo pill in 91 adults with moderate to severe OSA over four weeks. Researchers measured changes in breathing events during sleep and other symptoms to see which dose worked best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
Conditions
Explore the condition pages connected to this study.